DNA damage response in a 2D-culture model by diffusing alpha-emitters radiation therapy (Alpha-DaRT).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 05 2024
Historique:
received: 09 12 2023
accepted: 13 05 2024
medline: 21 5 2024
pubmed: 21 5 2024
entrez: 20 5 2024
Statut: epublish

Résumé

Diffusing alpha-emitters radiation therapy (Alpha-DaRT) is a unique method, in which interstitial sources carrying

Identifiants

pubmed: 38769339
doi: 10.1038/s41598-024-62071-6
pii: 10.1038/s41598-024-62071-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11468

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 20K23046
Organisme : Japan Society for the Promotion of Science
ID : 21K09855
Organisme : Japan Society for the Promotion of Science
ID : 20H03886

Informations de copyright

© 2024. The Author(s).

Références

Hall, E. J. & Giaccia, A. J. Radiobiology for the Radiologist 8th edn. (Wolters Kluwer Health, 2018).
Nikjoo, H., O’Neill, P., Wilson, W. E. & Goodhead, D. T. Computational approach for determining the spectrum of DNA damage induced by ionizing radiation. Radiat. Res. 156, 577–583. https://doi.org/10.1667/0033-7587(2001)156[0577:cafdts]2.0.co;2 (2001).
doi: 10.1667/0033-7587(2001)156[0577:cafdts]2.0.co;2 pubmed: 11604075
Matsuya, Y., Kai, T., Parisi, A., Yoshii, Y. & Sato, T. Application of a simple DNA damage model developed for electrons to proton irradiation. Phys. Med. Biol. https://doi.org/10.1088/1361-6560/ac9a20 (2022).
doi: 10.1088/1361-6560/ac9a20 pubmed: 36228611
Tateishi, U. Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer. Jpn. J. Clin. Oncol. 50, 349–356. https://doi.org/10.1093/jjco/hyaa004 (2020).
doi: 10.1093/jjco/hyaa004 pubmed: 32147685 pmcid: 7160915
Suominen, M. I., Wilson, T., Käkönen, S. M. & Scholz, A. The mode-of-action of targeted alpha therapy radium-223 as an enabler for novel combinations to treat patients with bone metastasis. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20163899 (2019).
doi: 10.3390/ijms20163899 pubmed: 31405099 pmcid: 6720648
Huclier-Markai, S., Alliot, C., Varmenot, N., Cutler, C. S. & Barbet, J. Alpha-emitters for immuno-therapy: A review of recent developments from chemistry to clinics. Curr. Top. Med. Chem. 12, 2642–2654. https://doi.org/10.2174/1568026611212230002 (2012).
doi: 10.2174/1568026611212230002 pubmed: 23339760
Pouget, J. P. & Constanzo, J. Revisiting the radiobiology of targeted alpha therapy. Front. Med. (Lausanne) 8, 692436. https://doi.org/10.3389/fmed.2021.692436 (2021).
doi: 10.3389/fmed.2021.692436 pubmed: 34386508
Arazi, L., Cooks, T., Schmidt, M., Keisari, Y. & Kelson, I. Treatment of solid tumors by interstitial release of recoiling short-lived alpha emitters. Phys. Med. Biol. 52, 5025–5042. https://doi.org/10.1088/0031-9155/52/16/021 (2007).
doi: 10.1088/0031-9155/52/16/021 pubmed: 17671351
Arazi, L., Cooks, T., Schmidt, M., Keisari, Y. & Kelson, I. The treatment of solid tumors by alpha emitters released from (224)Ra-loaded sources-internal dosimetry analysis. Phys. Med. Biol. 55, 1203–1218. https://doi.org/10.1088/0031-9155/55/4/020 (2010).
doi: 10.1088/0031-9155/55/4/020 pubmed: 20124656
Cooks, T. et al. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224. Int. J. Radiat. Oncol. Biol. Phys. 74, 966–973. https://doi.org/10.1016/j.ijrobp.2009.02.063 (2009).
doi: 10.1016/j.ijrobp.2009.02.063 pubmed: 19480976
Cooks, T. et al. Growth retardation and destruction of experimental squamous cell carcinoma by interstitial radioactive wires releasing diffusing alpha-emitting atoms. Int. J. Cancer 122, 1657–1664. https://doi.org/10.1002/ijc.23268 (2008).
doi: 10.1002/ijc.23268 pubmed: 18059026
Cooks, T. et al. Intratumoral 224Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control. Anticancer Res. 32, 5315–5321 (2012).
pubmed: 23225432
Lazarov, E. et al. Comparative in vitro microdosimetric study of murine- and human-derived cancer cells exposed to alpha particles. Radiat. Res. 177, 280–287. https://doi.org/10.1667/rr2664.1 (2012).
doi: 10.1667/rr2664.1 pubmed: 22077335
Arazi, L. Diffusing alpha-emitters radiation therapy: Approximate modeling of the macroscopic alpha particle dose of a point source. Phys. Med. Biol. 65, 015015. https://doi.org/10.1088/1361-6560/ab5b73 (2020).
doi: 10.1088/1361-6560/ab5b73 pubmed: 31766047
Heger, G., Roy, A., Dumančić, M. & Arazi, L. Alpha dose modeling in diffusing alpha-emitters radiation therapy-Part I: Single-seed calculations in one and two dimensions. Med. Phys. 50, 1793–1811. https://doi.org/10.1002/mp.16145 (2023).
doi: 10.1002/mp.16145 pubmed: 36464914
Heger, G., Dumančić, M., Roy, A. & Arazi, L. Alpha dose modeling in diffusing alpha-emitters radiation therapy. Part II: Lattice studies. Med. Phys. 50, 1812–1823. https://doi.org/10.1002/mp.16155 (2023).
doi: 10.1002/mp.16155 pubmed: 36517936
Epstein, L. et al. The low-LET radiation contribution to the tumor dose in diffusing alpha-emitters radiation therapy. Med. Phys. 51, 3020–3033. https://doi.org/10.1002/mp.16885 (2024).
doi: 10.1002/mp.16885 pubmed: 38096442
Zhang, I. P., Cohen, G. N. & Damato, A. L. A finite element method for modeling diffusion of alpha-emitting particles in tissue. Med. Phys. 51, 2263–2276. https://doi.org/10.1002/mp.16803 (2024).
doi: 10.1002/mp.16803 pubmed: 37878762
Popovtzer, A. et al. Initial safety and tumor control results from a “first-in-human” multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of locally advanced recurrent squamous cell carcinomas of the skin and head and neck. Int. J. Radiat. Oncol. Biol. Phys. 106, 571–578. https://doi.org/10.1016/j.ijrobp.2019.10.048 (2020).
doi: 10.1016/j.ijrobp.2019.10.048 pubmed: 31759075
D’Andrea, M. A. et al. Feasibility and safety of diffusing alpha-emitter radiation therapy for recurrent or unresectable skin cancers. JAMA Netw. Open 6, e2312824. https://doi.org/10.1001/jamanetworkopen.2023.12824 (2023).
doi: 10.1001/jamanetworkopen.2023.12824 pubmed: 37166798 pmcid: 10176125
Reitkopf-Brodutch, S. et al. Ablation of experimental colon cancer by intratumoral 224Radium-loaded wires is mediated by alpha particles released from atoms which spread in the tumor and can be augmented by chemotherapy. Int. J. Radiat. Biol. 91, 179–186. https://doi.org/10.3109/09553002.2015.959666 (2015).
doi: 10.3109/09553002.2015.959666 pubmed: 25179346
Nishri, Y. et al. Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts. Front. Oncol. 12, 888100. https://doi.org/10.3389/fonc.2022.888100 (2022).
doi: 10.3389/fonc.2022.888100 pubmed: 36237307 pmcid: 9552201
Mare, S. D. et al. Diffusing alpha-emitters radiation therapy promotes a proimmunogenic tumor microenvironment and synergizes with programmed cell death protein 1 blockade. Int. J. Radiat. Oncol. Biol. Phys. 115, 707–718. https://doi.org/10.1016/j.ijrobp.2022.08.043 (2023).
doi: 10.1016/j.ijrobp.2022.08.043 pubmed: 36031029
Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487–498. https://doi.org/10.1016/j.cell.2007.12.033 (2008).
doi: 10.1016/j.cell.2007.12.033 pubmed: 18267078
Kaida, A., Sawai, N., Sakaguchi, K. & Miura, M. Fluorescence kinetics in HeLa cells after treatment with cell cycle arrest inducers visualized with Fucci (fluorescent ubiquitination-based cell cycle indicator). Cell Biol. Int. 35, 359–363. https://doi.org/10.1042/cbi20100643 (2011).
doi: 10.1042/cbi20100643 pubmed: 21231917
Nojima, H., Kaida, A., Harada, H., Akiyama, M. & Miuraa, M. Effect of ablative dose irradiation on redistribution and radioresponse in a mouse xenograft model. Radiat. Res. 198, 632–638. https://doi.org/10.1667/rade-22-00096.1 (2022).
doi: 10.1667/rade-22-00096.1 pubmed: 36223173
Godwin, H. A. The biological chemistry of lead. Curr. Opin. Chem. Biol. 5, 223–227. https://doi.org/10.1016/s1367-5931(00)00194-0 (2001).
doi: 10.1016/s1367-5931(00)00194-0 pubmed: 11282351
Leggett, R. W. An age-specific kinetic model of lead metabolism in humans. Environ. Health Perspect. 101, 598–616. https://doi.org/10.1289/ehp.93101598 (1993).
doi: 10.1289/ehp.93101598 pubmed: 8143593 pmcid: 1519877
Kodaira, S. et al. Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors. PLoS One 12, e0178472. https://doi.org/10.1371/journal.pone.0178472 (2017).
doi: 10.1371/journal.pone.0178472 pubmed: 28658304 pmcid: 5489156
Mah, L. J., El-Osta, A. & Karagiannis, T. C. gammaH2AX: A sensitive molecular marker of DNA damage and repair. Leukemia 24, 679–686. https://doi.org/10.1038/leu.2010.6 (2010).
doi: 10.1038/leu.2010.6 pubmed: 20130602
Moeglin, E. et al. Uniform widespread nuclear phosphorylation of histone H2AX is an indicator of lethal DNA replication stress. Cancers (Basel) https://doi.org/10.3390/cancers11030355 (2019).
doi: 10.3390/cancers11030355 pubmed: 30871194
Tsuchida, E. et al. Effect of X-irradiation at different stages in the cell cycle on individual cell-based kinetics in an asynchronous cell population. PLoS One 10, e0128090. https://doi.org/10.1371/journal.pone.0128090 (2015).
doi: 10.1371/journal.pone.0128090 pubmed: 26086724 pmcid: 4472673
Yam, C. Q. X., Lim, H. H. & Surana, U. DNA damage checkpoint execution and the rules of its disengagement. Front. Cell Dev. Biol. 10, 1020643. https://doi.org/10.3389/fcell.2022.1020643 (2022).
doi: 10.3389/fcell.2022.1020643 pubmed: 36274841 pmcid: 9582513
Shimono, H. et al. Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency. Sci. Rep. 10, 20873. https://doi.org/10.1038/s41598-020-77969-0 (2020).
doi: 10.1038/s41598-020-77969-0 pubmed: 33257719 pmcid: 7705701
Sommer, S., Buraczewska, I. & Kruszewski, M. Micronucleus assay: The state of art, and future directions. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21041534 (2020).
doi: 10.3390/ijms21041534 pubmed: 33302436 pmcid: 7762598
Sasaki, H. Cell killing and division delay in asynchronous and synchronized HeLa cells irradiated with alpha particles or X rays. Radiat. Res. 99, 311–323 (1984).
doi: 10.2307/3576374 pubmed: 6463209
Mitchell, J. B., Bedford, J. S. & Bailey, S. M. Dose-rate effects in plateau-phase cultures of S3 HeLa and V79 cells. Radiat. Res. 79, 552–567 (1979).
doi: 10.2307/3575180 pubmed: 482612
Sinclair, W. & Morton, R. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat. Res. 29, 450–474 (1966).
doi: 10.2307/3572025 pubmed: 5924188
Rajon, D. A. et al. Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223. Int. J. Radiat. Biol. 97, 1217–1228. https://doi.org/10.1080/09553002.2021.1951392 (2021).
doi: 10.1080/09553002.2021.1951392 pubmed: 34232830 pmcid: 8560015
Gaillard, S., Pusset, D., de Toledo, S. M., Fromm, M. & Azzam, E. I. Propagation distance of the alpha-particle-induced bystander effect: The role of nuclear traversal and gap junction communication. Radiat. Res. 171, 513–520. https://doi.org/10.1667/rr1658.1 (2009).
doi: 10.1667/rr1658.1 pubmed: 19580486 pmcid: 2717798
Azzam, E. I., de Toledo, S. M. & Little, J. B. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc. Natl. Acad. Sci. USA 98, 473–478. https://doi.org/10.1073/pnas.98.2.473 (2001).
doi: 10.1073/pnas.98.2.473 pubmed: 11149936 pmcid: 14611

Auteurs

Hitomi Nojima (H)

Department of Dental Radiology and Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Atsushi Kaida (A)

Department of Dental Radiology and Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Yusuke Matsuya (Y)

Nuclear Science and Engineering Center, Japan Atomic Energy Agency, 2-4 Shirakata, Tokai, Ibaraki, 319-1195, Japan.
Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan.

Motohiro Uo (M)

Department of Advanced Biomaterials, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Ryo-Ichi Yoshimura (RI)

Department of Radiation Therapeutics and Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Lior Arazi (L)

Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, 8410501, Be'er-Sheva, Israel.

Masahiko Miura (M)

Department of Dental Radiology and Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan. masa.mdth@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH